Brandywine Realty Trust to Present at Nareit's REITweek: 2025 Investor Conference
Brandywine's presentation can be accessed live via webcast here and a replay will be available on the Investor Relations page of our website at www.brandywinerealty.com until June 13th.Brandywine Realty Trust (NYSE: BDN) is one of the largest, publicly traded, full-service, integrated real estate companies in the United States with a core focus in Philadelphia, PA and Austin, TX. Organized as a real estate investment trust (REIT), we own, develop, lease and manage an urban, town center and transit-oriented portfolio comprising 125 properties and 19.4 million square feet as of March 31, 2025. Our purpose is to shape, connect and inspire the world around us through our expertise, the relationships we foster, the communities in which we live and work, and the history we build together. For more information, please visit www.brandywinerealty.com.
Company / Investor Contact:
Tom WirthEVP & CFO610-832-7434 tom.wirth@bdnreit.com
Heather Crowell Gregory FCA 215-316-6271heather@gregoryfca.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Insider
12 minutes ago
- Business Insider
DBS Sticks to Its Buy Rating for Sea (SE)
DBS analyst Sachin Mittal maintained a Buy rating on Sea today and set a price target of $204.00. The company's shares closed yesterday at $174.66. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Mittal covers the Technology sector, focusing on stocks such as Accenture, Grab, and SenseTime Group, Inc. Class B. According to TipRanks, Mittal has an average return of 22.9% and a 72.82% success rate on recommended stocks. In addition to DBS, Sea also received a Buy from Benchmark Co.'s Fawne Jiang in a report issued yesterday. However, on August 12, Bank of America Securities reiterated a Hold rating on Sea (NYSE: SE).
Yahoo
21 minutes ago
- Yahoo
Flowers Foods (FLO) Q2 Earnings Report Preview: What To Look For
Packaged bakery food company Flower Foods (NYSE:FLO) will be reporting results this Friday before market hours. Here's what you need to know. Flowers Foods missed analysts' revenue expectations by 2.7% last quarter, reporting revenues of $1.55 billion, down 1.4% year on year. It was a softer quarter for the company, with a miss of analysts' EBITDA estimates and a significant miss of analysts' EPS estimates. Is Flowers Foods a buy or sell going into earnings? Read our full analysis here, it's free. This quarter, analysts are expecting Flowers Foods's revenue to grow 3.5% year on year to $1.27 billion, improving from its flat revenue in the same quarter last year. Adjusted earnings are expected to come in at $0.29 per share. The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Flowers Foods has missed Wall Street's revenue estimates six times over the last two years. Looking at Flowers Foods's peers in the perishable food segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Vital Farms delivered year-on-year revenue growth of 25.4%, beating analysts' expectations by 8%, and Fresh Del Monte Produce reported revenues up 3.8%, topping estimates by 2.2%. Vital Farms traded up 21.8% following the results while Fresh Del Monte Produce was also up 4.2%. Read our full analysis of Vital Farms's results here and Fresh Del Monte Produce's results here. There has been positive sentiment among investors in the perishable food segment, with share prices up 5.8% on average over the last month. Flowers Foods is up 9% during the same time and is heading into earnings with an average analyst price target of $18.13 (compared to the current share price of $16.76). Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.


Business Insider
27 minutes ago
- Business Insider
Piper Sandler Sticks to Their Hold Rating for Oscar Health (OSCR)
Piper Sandler analyst Jessica Tassan maintained a Hold rating on Oscar Health yesterday and set a price target of $13.00. The company's shares closed yesterday at $14.93. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Tassan is an analyst with an average return of -6.8% and a 36.08% success rate. Tassan covers the Healthcare sector, focusing on stocks such as Oscar Health, Omnicell, and UnitedHealth. In addition to Piper Sandler, Oscar Health also received a Hold from TR | OpenAI – 4o's Soren Coverra in a report issued on August 8. However, yesterday, Wells Fargo maintained a Sell rating on Oscar Health (NYSE: OSCR). Based on Oscar Health's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $3.05 billion and a net profit of $275.27 million. In comparison, last year the company earned a revenue of $2.14 billion and had a net profit of $177.37 million Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of OSCR in relation to earlier this year.